Inventor · disambiguated record
James Philip Johnson
Also filed as: JOHNSON JAMES PHILIP · JOHNSON JR JAMES PHILIP
16 granted patents·5 pending applications·256 citations·filing 2011–2024
95Inventor score
Top patents by PatentIndex Score
21 records- 0198US10087143B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2017·Granted Oct 2, 2018·19 cites·51 claims
- 0298US9758483B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2016·Granted Sep 12, 2017·20 cites·35 claims
- 0398US9393235B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·24 cites·26 claims
- 0498US9051270B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Jun 9, 2015·36 cites·29 claims
- 0597US10738009B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted Aug 11, 2020·10 cites·15 claims
- 0697US9783501B2Substituted quinolines as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·31 cites·23 claims
- 0796US9421196B2Amides as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Aug 23, 2016·23 cites·18 claims
- 0895US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0995US9108903B2Amides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Aug 18, 2015·33 cites·20 claims
- 1094US9139529B2Substituted quinoxalines as sodium channel modulatorsVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·26 cites·35 claims
- 1193US11673864B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Jun 13, 2023·2 cites·17 claims
- 1292US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 1391US11203571B2Sulfonamides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Dec 21, 2021·8 cites·26 claims
- 1491US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 1590US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 1681US8598164B2Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2011·Granted Dec 3, 2013·5 cites·68 claims
- 1776US2024408075A1Conjoint therapy for treating seizure disordersXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1875US2024342156A1Methods for treating painXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1965US2022288057A1Conjoint therapy for treating seizure disordersXENON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2062US2021213009A1Methods of treating painXENON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2147US2018162868A1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Philip Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →